lintuzumab
matuzumab
onartuzumab
sibrotuzumab
dalotuzumab
inotuzumab ozogamicin
dacetuzumab
conatumumab
patritumab
panitumumab
mapatumumab
oleclumab
drozitumab
tenatumomab
naptumomab estafenatox
lexatumumab
samalizumab
apolizumab
tucotuzumab
elotuzumab
sonepcizumab
tigatuzumab
inotuzumab
duligotuzumab
fontolizumab
ocrelizumab
teprotumumab
agonistic monoclonal antibody
cantuzumab
ipilimumab
bivatuzumab
lucatumumab
adecatumumab
tabalumab
pamrevlumab
figitumumab
acrixolimab
nofetumomab
lenzilumab
iratumumab
avelumab
cergutuzumab
zalutumumab
carlumab
pritumumab
durvalumab
labetuzumab
mogamulizumab
ozogamicin
-zumab